Late-Breaking Abstract Submissions

ASRS Regular, FIT, and International Members are invited to submit one late-breaking abstract even if they have already accepted an invitation to present a paper at the 2024 Annual Meeting. Non-members and Ophthalmology Resident Members may not submit an abstract in this category.

Requirements are as follows:

  • Priority will be given to first-time results of clinical trials that have not been presented to date. 
  • Abstracts must be true late breakers (i.e. data was not available at time of original abstract deadline in January).
  • Late-breaking abstracts will be interspersed into the scientific symposia on Wednesday, July 17 through Saturday, July 20. Members should ensure their availability over these dates before submitting.

Late-breaking abstract submissions are open until 11:59 PM Central Time on June 5, 2024.

Employees and owners of ineligible companies may not submit abstracts. Only current, active ASRS members can submit a late-breaker. Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

NOTE: Lead authors must attest to maintain complete control of educational content beginning with abstract submission through upload of the presentation. It is never appropriate for ineligible companies (or advertising, marketing, or communication firms whose clients are ineligible companies) to contact ASRS staff directly.

General requirements:

  • Substitute presenters are NOT allowed. If the first author cannot attend the meeting, the presentation must be withdrawn.
  • Submission of an abstract constitutes a commitment by the first author to present if selected. Presenters are required to register for the meeting and pay all applicable fees.
  • Only lead authors are required to submit a financial disclosure since they (and not co-authors) are considered to be in control of the educational content. Co-author names will be acknowledged; however, their disclosures will not be published or resolved.
  • Abstracts written by industry personnel on behalf of a doctor are not allowed. Since lead authors attest to maintain complete control of educational content, it is never appropriate for advertising, marketing, or communication firms whose clients are ineligible companies to contact ASRS staff directly.
  • Annual Meeting presenters retain copyright of their own materials for use elsewhere.

IMPORTANT: please be sure to read the FAQs about financial disclosures, especially if you hold an executive role with an ineligible company (i.e., named title such as Chief Officer). 

 CLICK HERE FOR FAQS ABOUT FINANCIAL DISCLOSURES

 


Notifications and Deadlines

The lead author will be contacted regarding acceptance at the email address supplied at the time of submission by June 19th. Final presentations must be uploaded at least 48-hours in advance of the talk in local Swedish time (CEST). 


Educational Objectives and Purpose

The goal of the ASRS 42nd Annual Meeting is to improve the competence of vitreoretinal specialists to diagnose and treat vitreous and retinal disorders and diseases using the most advanced concepts and techniques available. The ASRS 42nd Annual Meeting will provide a forum for rapid dissemination of the most recent scientific research results to the target audience in attendance. Its purpose is to allow the presentation of new and ongoing research data to assist practicing vitreoretinal specialists in maintaining knowledge and skills in their medical field.

Upon completion of the scientific sessions, participants shall be able to describe the findings, diagnosis, and treatment of various vitreoretinal disorders such as macular degeneration, choroidal neovascularization, diabetic retinopathy, venous occlusive disease, macular holes, epiretinal membranes, ocular inflammatory disease, tumors, proliferative vitreoretinopathy, retinopathy of prematurity, retinal degenerations, and retinal detachment.


Accreditation Statement and CME Credit

The American Society of Retina Specialists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Retina Specialists designates this Other activity (blended live and enduring material) for a maximum of 23.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Society of Retina Specialists designates this enduring material for a maximum of 22.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 


 

Notifications and Deadlines

January 3, 2024

  • Last day to apply for membership (all references and documentation must be received on or before this date)

January 30, 2024

  • Abstract deadline for papers/papers on demand, posters, cases, and films

March 25, 2024

  • Notifications sent out for papers/papers on demand, posters, and films

March 26, 2024

  • Notifications sent out for cases

April 10, 2024

  • Deadline to accept invitations to present papers, papers on demand, posters, cases, and films

April 24, 2024

  • Speaker guidelines and presentation upload instructions sent to lead authors

April 24, 2024

  • Late breaking abstract submissions open

 May 12, 2024

  • Last date to become a member to register for the Annual Meeting

May 15, 2024

  • Completed Film Festival video uploads 

June 3, 2024

  • Completed papers-on-demand and cases-on-demand

June 5, 2024

  • Late breaking abstract submissions close at 11:59 PM CT

June 10, 2024

  • Completed E-poster uploads

June 20, 2024

  • Final Retina Case Conference slide decks

 June 25, 2024

  • Expert Panel presenter slide decks

48-hours in advance of talk (local Sweden time CEST)

  • Paper  slide decks

Questions?

Stacy Kiff
Vice President of Education
(312) 477-8863
stacy.kiff@asrs.org